Navigation Links
Albemarle Raises Prices of Specialty Aluminas
Date:11/30/2007

Increase Includes Flame Retardants, Fillers, Pigments and Ceramic Oxides

BATON ROUGE, La., Nov. 30 /PRNewswire-FirstCall/ -- Albemarle Corporation (NYSE: ALB), the world leader in the development and marketing of aluminum trihydroxide and other specialty aluminas for flame retardants, fillers and other industrial applications, will increase the prices for all of its specialty aluminas up to 15 percent, effective globally on all shipment made on or after January 1, 2008, or as contracts allow. The increases are needed to help offset the rapidly escalating raw material prices, raw material freight costs and energy costs required to manufacture these products.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO )

The price increases will take effect for all of the following products:

-- MARTINAL(R) aluminum trihydroxide (ATH) flame retardants

-- MARTIFIN(R) specialty alumina pigments

-- MARTOXID(R) aluminum oxide products

-- COMPALOX(R) activated aluminas

Plastics compounders and polymer manufacturers use Albemarle's MARTINAL flame retardants and technical services to add life-saving properties to wire & cable, roofing, flooring, pipe and other building and construction materials. MARTINAL fillers are also used to improve injection-molded plastic parts, insulating foams and certain electrical and electronic parts.

Albemarle's specialty ATH products are applied as pigmented fillers and coating minerals in the paper and board industry (MARTIFIN specialty pigments); as high-quality calcined aluminas for the industrial ceramics, refractory, and surface treatment industries (MARTOXID aluminum oxides); and as adsorbents and catalysts in chemical processes and environmental protection (COMPALOX activated aluminas).

Albemarle Corporation, headquartered in Richmond, Virginia, is a leading global developer, manufacturer and marketer of highly engineered specialty chemicals for consumer electronics; petroleum and petrochemical processing; transportation and industrial products; pharmaceuticals; agricultural products; and construction and packaging materials. The Company operates in three business segments-Polymer Additives, Catalysts and Fine Chemicals, and serves customers in approximately 100 countries. Learn more about Albemarle at http://www.albemarle.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.


'/>"/>
SOURCE Albemarle Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Albemarle to Increase Price of Ibuprofen
2. Albemarle Reports Third Quarter 2007 Results
3. Albemarle to Raise Prices of Dibromomethane
4. BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank
5. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
6. Fifth Annual Avon Walk for Breast Cancer Los Angeles Raises $4.3 Million
7. AHIP Praises Bipartisan Senate Vote on Mental Health Parity
8. Union President Praises Hillary Clintons Health Plan
9. Progression of SIV infection in monkeys raises
10. Computerized Jump Rope Raises Funds for Breast Cancer Research
11. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology: